GB1198301A - Perfluoroalkylsulfonamides - Google Patents
PerfluoroalkylsulfonamidesInfo
- Publication number
- GB1198301A GB1198301A GB47927/67A GB4792767A GB1198301A GB 1198301 A GB1198301 A GB 1198301A GB 47927/67 A GB47927/67 A GB 47927/67A GB 4792767 A GB4792767 A GB 4792767A GB 1198301 A GB1198301 A GB 1198301A
- Authority
- GB
- United Kingdom
- Prior art keywords
- aqueous
- sulphonamides
- signifies
- oct
- heteroatom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003456 sulfonamides Chemical class 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 235000006491 Acacia senegal Nutrition 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000165918 Eucalyptus papuana Species 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- -1 ammonium cations Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 abstract 1
- 230000001716 anti-fugal effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000000749 insecticidal effect Effects 0.000 abstract 1
- 238000005065 mining Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001069 nematicidal effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 230000000361 pesticidal effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000008635 plant growth Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000008174 sterile solution Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58833866A | 1966-10-21 | 1966-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1198301A true GB1198301A (en) | 1970-07-08 |
Family
ID=24353436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB47927/67A Expired GB1198301A (en) | 1966-10-21 | 1967-10-20 | Perfluoroalkylsulfonamides |
Country Status (5)
Country | Link |
---|---|
BR (1) | BR6794063D0 (enrdf_load_stackoverflow) |
CH (1) | CH513136A (enrdf_load_stackoverflow) |
DE (1) | DE1668420B2 (enrdf_load_stackoverflow) |
FR (1) | FR1579473A (enrdf_load_stackoverflow) |
GB (1) | GB1198301A (enrdf_load_stackoverflow) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548547B1 (en) | 1998-07-08 | 2003-04-15 | Aventis Pharma Deutschland Gmbh | Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
WO2006078283A3 (en) * | 2004-04-30 | 2006-10-12 | Genentech Inc | Quinoxaline inhibitors of hedgehog signalling |
US8722702B2 (en) | 2006-11-22 | 2014-05-13 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US8741920B2 (en) | 2009-08-03 | 2014-06-03 | Hoffmann-La Roche, Inc. | Process for the manufacture of pharmaceutically active compounds |
US8865735B2 (en) | 2011-02-21 | 2014-10-21 | Hoffman-La Roche Inc. | Solid forms of a pharmaceutically active substance |
AU2012200933B2 (en) * | 2005-06-22 | 2015-04-30 | Plexxikon, Inc. | Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors |
US9096593B2 (en) | 2009-11-06 | 2015-08-04 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
EP2395004B1 (en) * | 2005-06-22 | 2016-01-20 | Plexxikon Inc. | Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors |
US9447089B2 (en) | 2009-04-03 | 2016-09-20 | Plexxikon Inc. | Compositions and uses thereof |
US9469640B2 (en) | 2007-07-17 | 2016-10-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
EP3760615A4 (en) * | 2018-02-27 | 2021-07-14 | Nippon Soda Co., Ltd. | HETEROARYL SULFONAMIDE COMPOUND AND PEST CONTROL AGENT |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3647874A (en) * | 1970-04-13 | 1972-03-07 | Riker Laboratories Inc | N-cyanobenzoylhaloalkylsulfonanilides |
US3661990A (en) * | 1970-04-13 | 1972-05-09 | Riker Laboratories Inc | N-alkylsulfonyl benzoylhaloalkylsulfonanilides |
US3972926A (en) * | 1971-01-04 | 1976-08-03 | Riker Laboratories, Inc. | Substituted trifluoromethanesulfonanilides |
US3981914A (en) * | 1971-08-03 | 1976-09-21 | Minnesota Mining And Manufacturing Company | N-alkylsulfonylperfluoroalkanesulfonanilides |
US4005141A (en) | 1972-07-03 | 1977-01-25 | Minnesota Mining And Manufacturing Company | Perfluoroalkylsulfonamidoaryl compounds |
US3996277A (en) | 1974-11-14 | 1976-12-07 | Minnesota Mining And Manufacturing Company | 4-Methylthio-2-trifluoromethylmethanesulfonanilide and derivatives thereof |
KR840001133A (ko) * | 1981-08-10 | 1984-03-28 | 히지가다 다께시 | 트리플루오로메탄술폰아닐리드 유도체의 제조방법 |
DE3834704A1 (de) * | 1988-10-07 | 1990-06-07 | Schering Ag | Fluorsubstituierte benzolderivate |
US20070238700A1 (en) * | 2006-04-10 | 2007-10-11 | Winzenberg Kevin N | N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
-
1967
- 1967-10-20 GB GB47927/67A patent/GB1198301A/en not_active Expired
- 1967-10-20 DE DE1967M0075958 patent/DE1668420B2/de active Granted
- 1967-10-20 CH CH1466867A patent/CH513136A/de not_active IP Right Cessation
- 1967-10-20 BR BR194063/67A patent/BR6794063D0/pt unknown
- 1967-10-20 FR FR1579473D patent/FR1579473A/fr not_active Expired
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6809089B2 (en) | 1998-07-08 | 2004-10-26 | Aventis Pharma Deutschland Gmbh | Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
US7351703B2 (en) | 1998-07-08 | 2008-04-01 | Sanofi-Aventis Deutschland Gmbh | Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
US6548547B1 (en) | 1998-07-08 | 2003-04-15 | Aventis Pharma Deutschland Gmbh | Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
WO2006078283A3 (en) * | 2004-04-30 | 2006-10-12 | Genentech Inc | Quinoxaline inhibitors of hedgehog signalling |
JP2007535569A (ja) * | 2004-04-30 | 2007-12-06 | ジェネンテック,インコーポレイティド | ヘッジホッグシグナル伝達のキノキサリン阻害剤 |
AU2005325267B2 (en) * | 2004-04-30 | 2010-11-04 | Curis Inc. | Quinoxaline inhibitors of the hedgehog signalling pathway |
US8273743B2 (en) | 2004-04-30 | 2012-09-25 | Curis, Inc. | Quinoxaline inhibitors of the hedgehog signalling |
CN101018783B (zh) * | 2004-04-30 | 2012-11-21 | 遗传技术研究公司 | Hedgehog信号传导途径的喹喔啉抑制剂 |
AU2012200933B2 (en) * | 2005-06-22 | 2015-04-30 | Plexxikon, Inc. | Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors |
EP2395004B1 (en) * | 2005-06-22 | 2016-01-20 | Plexxikon Inc. | Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors |
US9487515B2 (en) | 2006-11-22 | 2016-11-08 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US8722702B2 (en) | 2006-11-22 | 2014-05-13 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US9169250B2 (en) | 2006-11-22 | 2015-10-27 | Plexxikon Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US10426760B2 (en) | 2007-07-17 | 2019-10-01 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9844539B2 (en) | 2007-07-17 | 2017-12-19 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9469640B2 (en) | 2007-07-17 | 2016-10-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9663517B2 (en) | 2009-04-03 | 2017-05-30 | Plexxikon Inc. | Compositions and uses thereof |
US9447089B2 (en) | 2009-04-03 | 2016-09-20 | Plexxikon Inc. | Compositions and uses thereof |
US8741920B2 (en) | 2009-08-03 | 2014-06-03 | Hoffmann-La Roche, Inc. | Process for the manufacture of pharmaceutically active compounds |
US9096593B2 (en) | 2009-11-06 | 2015-08-04 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US11337976B2 (en) | 2011-02-07 | 2022-05-24 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US12076322B2 (en) | 2011-02-07 | 2024-09-03 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
US8865735B2 (en) | 2011-02-21 | 2014-10-21 | Hoffman-La Roche Inc. | Solid forms of a pharmaceutically active substance |
US9695169B2 (en) | 2012-05-31 | 2017-07-04 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
EP3760615A4 (en) * | 2018-02-27 | 2021-07-14 | Nippon Soda Co., Ltd. | HETEROARYL SULFONAMIDE COMPOUND AND PEST CONTROL AGENT |
Also Published As
Publication number | Publication date |
---|---|
DE1668420A1 (de) | 1970-06-25 |
FR1579473A (enrdf_load_stackoverflow) | 1969-08-29 |
BR6794063D0 (pt) | 1973-09-18 |
CH513136A (de) | 1971-09-30 |
DE1668420B2 (de) | 1976-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1198301A (en) | Perfluoroalkylsulfonamides | |
GB1147379A (en) | 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts | |
GB1178034A (en) | Hydroxy-Cyclohexylamines | |
GB1154744A (en) | Disubstituted Aminoethanols | |
GB1434830A (en) | 5-6-benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity | |
GB1228736A (enrdf_load_stackoverflow) | ||
GB1322512A (en) | Substituted azetidinones and process for their manufacture | |
IL43722A (en) | 2-aminomethyleneindanones and pharmaceutical compositions containing them | |
GB1450211A (en) | 5-methylthiopyrimidines their preparation and use | |
ES8800235A1 (es) | Un procedimiento para preparar un isomero sin de un compues-to de cefem | |
GB1141936A (en) | Improvements in or relating to benzimidazole derivatives | |
GB1530074A (en) | Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents | |
GB1195199A (en) | Improvements in Compositions comprising Insulin. | |
ES427078A1 (es) | Un metodo para la preparacion de una monosal de adicion de acido de un acido organico farmaceuticamente aceptable y una2,4-diaminopirimidina. | |
ES462229A1 (es) | Un procedimiento para preparar una indol dihiindolcarboxami-da dimerica. | |
GB1262292A (en) | Novel thiazoline derivatives, the preparation thereof and compositions containing the same | |
GB1363047A (en) | Pyrimidine derivative process for its preparation and its use as a medicament | |
GB1296802A (enrdf_load_stackoverflow) | ||
GB1073521A (en) | Indole derivatives | |
PH15876A (en) | Novel imidazole derivatives and pharmaceutical preparations thereof | |
GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
GB1143779A (enrdf_load_stackoverflow) | ||
GB1354734A (en) | Pharmaceutical compositions comprising aminoguanidine derivatives | |
IE39639B1 (en) | N-substituted cycloserine compounds | |
GB1050565A (enrdf_load_stackoverflow) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
429A | Application made for amendment of specification (sect. 29/1949) | ||
429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
PE20 | Patent expired after termination of 20 years |